SCHEMBL4450124

SCHEMBL4450124

O=C1C=CC(O)=C(O)C1=O.[Pb]

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 2/20 0.38
CDC25B P30305 2/20 0.38
AURKB Q96GD4 2/20 0.38
CYP1A1 P04798 1/20 0.38
CYP1A2 P05177 1/20 0.38
TXNRD1 Q16881 1/20 0.38
TXNRD3 Q86VQ6 1/20 0.38
COPS5 Q92905 1/20 0.38
TXNRD2 Q9NNW7 1/20 0.38
ALDH1A1 P00352 5/20 0.37
MEN1 O00255 4/20 0.37
MAPT P10636 4/20 0.37
ALOX15 P16050 4/20 0.37
KMT2A Q03164 4/20 0.37
KDM4E B2RXH2 4/20 0.37
BLM P54132 3/20 0.37
TDP1 Q9NUW8 3/20 0.37
ALOX12 P18054 2/20 0.37
PTPRC P08575 2/20 0.37
HSD17B10 Q99714 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4443898 0.97 CDC25B (0.39) AURKACDC25BAURKBCYP1A1CYP1A2
Phenol SCHEMBL11668511 0.81 TDP1 (0.48) AURKACDC25BAURKBCYP1A1CYP1A2
SCHEMBL11664840 0.78
SCHEMBL594152 0.70 CDC25B (0.47) AURKACDC25BAURKBCYP1A1CYP1A2
SCHEMBL10866768 0.69 CDC25B (0.41) AURKACDC25BAURKBCYP1A1CYP1A2
SCHEMBL28498261 0.67 CDC25B (0.45) AURKACDC25BAURKBCYP1A1CYP1A2
SCHEMBL12033671 0.65
SCHEMBL5536618 0.60 AURKA (0.33) AURKACDC25BAURKBCYP1A1CYP1A2
SCHEMBL3296419 0.60 AURKA (0.33) AURKACDC25BAURKBCYP1A1CYP1A2
SCHEMBL21871795 0.60 AURKA (0.33) AURKACDC25BAURKBCYP1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140378522-A1 UNIFYING MECHANISM AND METHODS TO PREVENT CANCER AND NEURODEGENERATIVE DISEASES PREVENTION, L.L.C. (US) 2014-12-25 US disclosed
US-20090312391-A1 UNIFYING MECHANISM AND METHODS TO PREVENT CANCER AND NEURODEGENERATIVE DISEASES PREVENTION, L.L.C. (US) 2009-12-17 US disclosed
US-20050164911-A1 By administering N-Acetylcysteine (NAC), and/or melatonin; cancer diagnosis by detecting or determining the amount of dopamine metabolites; quinone reductase inducer, lipoic acid or salt, and/or resveratrol or salt may be co-administered PREVENTION LLC 2005-07-28 US disclosed
WO-2003077900-A1 A UNIFYING MECHANISM AND METHODS TO PREVENT CANCER AND NEURODEGENERATIVE DISEASES PREVENTION, L.L.C. (US) 2003-09-25 WO disclosed